RBM7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.921000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.990200E-01
Normal-vs-Stage2
7.693600E-01
Normal-vs-Stage3
1.133600E-01
Normal-vs-Stage4
4.996600E-01
Stage1-vs-Stage2
7.034400E-01
Stage1-vs-Stage3
2.748800E-01
Stage1-vs-Stage4
1.526030E-01
Stage2-vs-Stage3
2.253600E-01
Stage2-vs-Stage4
2.521200E-01
Stage3-vs-Stage4
4.420000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.758200E-01
Normal-vs-AfricanAmerican
9.784400E-01
Normal-vs-Asian
4.705200E-01
Caucasian-vs-AfricanAmerican
5.341200E-01
Caucasian-vs-Asian
4.636200E-01
AfricanAmerican-vs-Asian
3.268000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.110400E-01
Normal-vs-Female
6.810400E-01
Male-vs-Female
8.720400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.905400E-01
Normal-vs-Age(41-60Yrs)
8.377800E-01
Normal-vs-Age(61-80Yrs)
5.027400E-01
Normal-vs-Age(81-100Yrs)
5.079800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.926800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.293600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.387200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.362000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.121160E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.883800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.971000E-01
Normal-vs-Daily Drinker
6.676600E-01
Normal-vs-Weekly Drinker
2.037800E-01
Normal-vs-Occasional Drinker
8.813800E-01
Normal-vs-Social Drinker
4.787400E-01
Non Drinker-vs-Daily Drinker
8.917000E-01
Non Drinker-vs-Weekly Drinker
4.728200E-01
Non Drinker-vs-Occasional Drinker
1.273450E-01
Non Drinker-vs-Social Drinker
9.275000E-01
Daily Drinker-vs-Weekly Drinker
4.677400E-01
Daily Drinker-vs-Occasional Drinker
2.743600E-01
Daily Drinker-vs-Social Drinker
9.643200E-01
Weekly Drinker-vs-Occasional Drinker
5.473500E-02
Weekly Drinker-vs-Social Drinker
4.170600E-01
Occasional Drinker-vs-Social Drinker
2.172600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.229400E-01
Normal-vs-Grade 2
7.728400E-02
Normal-vs-Grade 3
1.072830E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.762400E-03
Grade 1-vs-Grade 3
2.076100E-03
Grade 1-vs-Grade 4
4.229400E-01
Grade 2-vs-Grade 3
1.109550E-01
Grade 2-vs-Grade 4
7.728400E-02
Grade 3-vs-Grade 4
1.072830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.727200E-01
Normal-vs-NonDiabetic
6.356000E-01
Diabetic-vs-NonDiabetic
5.760000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.683400E-01
Normal-vs-NoPancreatitis
6.508200E-01
Pancreatitis-vs-NoPancreatitis
9.500000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.160600E-01
Normal-vs-N1
8.274200E-01
N0-vs-N1
1.043180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.145200E-01
Normal-vs-TP53-NonMutant
3.634200E-01
TP53-Mutant-vs-TP53-NonMutant
7.401500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
